ARTICLE | Company News
ArcherDx, Enzymatics deal
September 16, 2013 7:00 AM UTC
Tool supplier Enzymatics acquired cancer-centric sequencing kit and software company ArcherDx in a deal valued up to $50 million comprised of cash, equity and milestones. ArcherDx co-founder and CEO J...